Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Ju

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cellular Immunology|April 15, 1988
Abnormal T cells from MRL/Mp-lpr/lpr mice do not respond to anti-T-cell-receptor antibody or tumor promoter and calcium ionophore A23187 despite the presence of the T-cell-receptor complex and protein kinase cM S Sy, P T Wang, S T Ju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicityS Jodo, A M Hohlbaum, S Xiao, et al.
European Journal of Immunology|February 1, 1996
Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responsesM Ozdemirli, M El-Khatib, L C Foote, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1983
Structural bases for public idiotypic specificities of monoclonal antibodies directed against poly(Glu60Ala30Tyr10) and poly(Glu60Ala40) random copolymersJ Ruf, C Tonnelle, J Rocca-Serra, et al.
Nature|February 2, 1995
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationS T Ju, D J Panka, H Cui, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Inducible resistance to Fas-mediated apoptosis in primary B lymphocytesT L Rothstein, L C Foote, T J Schneider, et al.
Nature|March 9, 1995
Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cellsT L Rothstein, J K Wang, D J Panka, et al.
Annals of Internal Medicine|January 15, 1994
Liver transplantation as a treatment for familial amyloidotic polyneuropathyM Skinner, W D Lewis, L A Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1996
Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cellsL C Foote, T J Schneider, G M Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alphaI R Rifkin, P L Channavajhala, H L Kiefer, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cellular Immunology|April 15, 1988
Abnormal T cells from MRL/Mp-lpr/lpr mice do not respond to anti-T-cell-receptor antibody or tumor promoter and calcium ionophore A23187 despite the presence of the T-cell-receptor complex and protein kinase cM S Sy, P T Wang, S T Ju, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicityS Jodo, A M Hohlbaum, S Xiao, et al.
European Journal of Immunology|February 1, 1996
Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responsesM Ozdemirli, M El-Khatib, L C Foote, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1983
Structural bases for public idiotypic specificities of monoclonal antibodies directed against poly(Glu60Ala30Tyr10) and poly(Glu60Ala40) random copolymersJ Ruf, C Tonnelle, J Rocca-Serra, et al.
Nature|February 2, 1995
Fas(CD95)/FasL interactions required for programmed cell death after T-cell activationS T Ju, D J Panka, H Cui, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
Inducible resistance to Fas-mediated apoptosis in primary B lymphocytesT L Rothstein, L C Foote, T J Schneider, et al.
Nature|March 9, 1995
Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cellsT L Rothstein, J K Wang, D J Panka, et al.
Annals of Internal Medicine|January 15, 1994
Liver transplantation as a treatment for familial amyloidotic polyneuropathyM Skinner, W D Lewis, L A Jones, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1996
Intracellular signaling for inducible antigen receptor-mediated Fas resistance in B cellsL C Foote, T J Schneider, G M Fischer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alphaI R Rifkin, P L Channavajhala, H L Kiefer, et al.
Pageof 11